Cases & Deals

Shionogi obtains settlement entitling it to royalties on European Union sales of drug for treatment of fatal lung disease

Clients Shionogi & Co., Ltd.

Jones Day represented Shionogi & Co., Ltd. in a royalty dispute with InterMune, Inc. concerning sales of Esbriet® for treatment of Idiopathic Pulmonary Fibrosis ("IPF"), obtaining a settlement entitling Shionogi to royalties on InterMune's sales in the European Union.

Shionogi & Co., Ltd. v. InterMune, Inc., Case No. 3:12-cv-03495-EDL (N.D. Cal.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.